Skip to main content

Table 3 The effects of hyperlipidemia on arterial stiffness without recommended for statin therapy at baselinea

From: Prolonged hyperlipidemia exposure increases the risk of arterial stiffness in young adults: a cross-sectional study in a cohort of Chinese

Group Model 1
OR (95% CI)
P P trend Model 2
OR (95% CI)
P P trend
Age (year) variable
[35–55] 0 1(Ref)    1(Ref)   
[1–5) 1.42 (1.30–1.56) < 0.01   1.16 (1.03–1.30) < 0.01  
[5–10] 2.03 (1.84–2.25) < 0.01 < 0.01 1.38 (1.20–1.59) < 0.01 < 0.01
[35–40) 0 1(Ref)    1(Ref)   
[1–5) 1.63 (1.32–2.00) < 0.01   1.18 (0.91–1.54) 0.23  
[5–10] 1.90 (1.48–2.44) < 0.01 < 0.01 1.18 (0.84–1.65) 0.36 0.30
[40–45) 0 1(Ref)    1(Ref)   
[1–5) 1.51 (1.24–1.84) < 0.01   1.25 (0.99–1.65) 0.05  
[5–10] 2.23 (1.79–2.78) < 0.01 < 0.01 1.52 (1.13–2.06) < 0.01 < 0.01
[45–50) 0 1(Ref)    1(Ref)   
[1–5) 1.26 (1.07–1.50) 0.01   1.14 (0.93–1.41) 0.26  
[5–10] 1.72 (1.43–2.07) < 0.01 < 0.01 1.37 (1.07–1.76) 0.02 0.02
[50–55] 0 1(Ref)    1(Ref)   
[1–5) 1.07 (0.85–1.22) 0.86   1.07 (0.84–1.34) 0.66  
[5–10] 1.38 (1.34–1.68) < 0.01 < 0.01 1.38 (1.05–1.81) 0.03 0.02
  1. Model 1 unadjust;
  2. Model 2 adjust age, gender, systolic blood pressure, high-density lipoprotein cholesterol, waist circumference, physical exercise, anti-hypertensive treatment, smoking, alcohol consumption, diabetes, baseline low-density lipoprotein cholesterol;
  3. alow-density lipoprotein cholesterol ≥4.9 or total cholesterol ≥7.2; diabetes and 1.8 ≤ low-density lipoprotein cholesterol < 4.9 or 3.1 ≤ total cholesterol< 7.2 and age ≥ 40